A SECRET WEAPON FOR RETATRUTIDE

Semaglutide is revealed to result in medullary thyroid cell carcinoma in rodents. Even though its scientific relevance to people is not known, the FDA advises not to administer this drug in All those with a private or loved ones record of medullary thyroid carcinoma. Semaglutide also poses a threat of pancreatitis and dehydration.Jillian Kubala, MS